HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company's Gene Expression Panels include HTG Research Use Only (RUO) Panels and HTG EdgeSeq Research Use Only (RUO) Panels, such as the HTG Transcriptome Panel, HTG EdgeSeq miRNA Whole Transcriptome Assay, HTG EdgeSeq Oncology Biomarker Panel, HTG EdgeSeq Precision Immuno-Oncology Panel, HTG EdgeSeq Immune Response Panel, HTG EdgeSeq Pan B-Cell Lymphoma Panel, HTG EdgeSeq Mouse mRNA Tumor Response Panel, and HTG EdgeSeq DLBCL Cell of Origin Assay. The HTG EdgeSeq system provides gene expression profiling for researchers, laboratory staff, and biomarker leads in discovery, translational medicine, and oncology applications. VERI/O Laboratory Services is a molecular lab providing gene expression profiling results.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Delayed OTC Markets Other stock markets 12:04:00 2026-07-13 EDT			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		0.00%	-

25-05-21	Motion For Case Conversion Approved for HTG Molecular Diagnostics, Inc.	CI
25-04-27	Motion for Case Conversion Filed by HTG Molecular Diagnostics, Inc.	CI

Market Cap	2.88K 2.53K 2.35K 2.16K 4.05K 277K 4.12K 27.91K 10.91K 136K 10.8K 10.57K 471K	P/E 2021	-2.19x	P/E 2022	-0.16x
Enterprise Value	-3.41M -2.99M -2.78M -2.56M -4.8M -328M -4.87M -33.06M -12.92M -161M -12.8M -12.52M -558M	EV / Sales 2021	3.96x	EV / Sales 2022	0.04x
Free-Float	99.86%	Yield 2021 *	-	Yield 2022	-

25-05-21	Motion For Case Conversion Approved for HTG Molecular Diagnostics, Inc.	CI
25-04-27	Motion for Case Conversion Filed by HTG Molecular Diagnostics, Inc.	CI
23-08-25	Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc.	CI
23-08-16	Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc.	CI
23-07-21	Trustee/Examiner Appointed Under Chapter 11 for HTG Molecular Diagnostics, Inc.	CI
23-06-14	HTG Molecular Diagnostics, Inc.(OTCPK:HTGM.Q) dropped from NASDAQ Composite Index	CI
23-06-08	HTG Molecular Diagnostics, Inc.(NasdaqCM:HTGM) dropped from S&P TMI Index	CI
23-06-06	HTG MOLECULAR DIAGNOSTICS SHARES HIT RECORD LOW AFTER CO FILES F…	RE
23-06-05	Htg Molecular Diagnostics, Inc. Announces Termination of Employment of Byron T. Lawson as Senior Vice President and Chief Commercial Officer	CI
23-06-05	HTG Molecular Diagnostics, Inc. Filed for Bankruptcy	CI
23-05-18	HTG Molecular Diagnostics, Inc. to Highlight the Advantages of its Drug Discovery Engine at the 2023 Biotechnology Innovation Organization	CI
23-05-17	Top Premarket Gainers	MT
23-05-10	HTG Molecular Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

23-04-03	HC Wainwright Adjusts Price Target on HTG Molecular Diagnostics to $6 From $15, Maintains Buy Rating	MT
22-08-15	HC Wainwright Adjusts Price Target on HTG Molecular Diagnostics to $2 From $3, Reiterates Buy Rating	MT
22-05-16	HC Wainwright Adjusts HTG Molecular Diagnostics' Price Target to $3 from $4, Keeps Buy Rating	MT
22-03-30	Craig-Hallum Adjusts HTG Molecular Diagnostics' Price Target to $3 from $8, Keeps Buy Rating	MT
22-03-30	HC Wainwright Adjusts HTG Molecular Diagnostics' Price Target to $4 from $9, Keeps Buy Rating	MT

HTG Molecular Diagnostics, Inc. Stock

Stocks

HTGMQ

US40434H3021

Advanced Medical Equipment & Technology

Valuation: HTG Molecular Diagnostics, Inc.

Chart: HTG Molecular Diagnostics, Inc.

Latest news : HTG Molecular Diagnostics, Inc.

Analysts' recommendations: HTG Molecular Diagnostics, Inc.

Press Releases: HTG Molecular Diagnostics, Inc.

Quotes and Performance

Course Extremes

Latest insider transactions

Medical Diagnostic & Testing Equipment

Financials

Company Profile

23-06-08	HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
23-05-18	HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention	AQ
23-05-16	HTG Highlights the Advantages of Its Drug Discovery Engine	AQ
23-05-10	HTG Molecular Diagnostics : Reports First Quarter 2023 Results and Provides Recent Business Highlights - Form 8-K	PU
23-05-10	HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights	AQ

Current year	0		0
1 year	0		0
3 years	0		0.59
5 years	0		83.76
10 years	0		2,385

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/8/23	Stephen Barat	Sell	Senior VP of Therapeutics	888	0.0401%
3/31/23	Stephen Barat	Tax	Senior VP of Therapeutics	52	0.0056%
2/2/23	Stephen Barat	Other	Senior VP of Therapeutics	7,610	0.8264%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
HTG MOLECULAR DIAGNOSTICS, INC.	-99.00%	0.00%	-	-	2
SARTORIUS AG	-2.08%	-9.10%	+12.43%	-42.27%	15.54B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+4.07%	+9.27%	+1.83%	+92.76%	1.65B
QUIDELORTHO CORPORATION	+6.14%	+3.38%	-34.30%	-80.21%	1.09B
ECKERT & ZIEGLER SE	+1.65%	-4.39%	-39.14%	+11.29%	948M
CONTEC MEDICAL SYSTEMS CO.,LTD	+3.70%	-2.12%	-43.46%	-54.33%	609M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+1.10%	-4.29%	-50.51%	-58.91%	505M
VAREX IMAGING CORPORATION	+1.60%	+4.71%	+40.76%	-51.67%	460M
REVENIO GROUP OYJ	+1.49%	-2.39%	-56.68%	-61.08%	365M
CELLAVISION AB	+1.29%	-4.03%	-20.93%	-33.89%	344M
Average	-7.93%	-2.05%	-21.11%	-30.92%	2.15B
Weighted average by Cap.	-0.80%	-6.77%	+2.81%	-32.62%

	2021	2022
Net sales	8.91M 7.82M 7.28M 6.68M 12.54M 858M 12.74M 86.39M 33.75M 422M 33.44M 32.72M 1.46B	6.37M 5.59M 5.2M 4.77M 8.97M 613M 9.1M 61.75M 24.12M 301M 23.9M 23.38M 1.04B
Net income	-17.15M -15.06M -14M -12.85M -24.15M -1.65B -24.52M -166M -64.97M -812M -64.36M -62.98M -2.81B	-21.59M -18.97M -17.64M -16.19M -30.41M -2.08B -30.88M -209M -81.83M -1.02B -81.07M -79.32M -3.53B
Net Debt	-5.74M -5.04M -4.69M -4.3M -8.08M -552M -8.2M -55.64M -21.74M -272M -21.54M -21.07M -939M	-3.41M -3M -2.79M -2.56M -4.8M -329M -4.88M -33.09M -12.93M -162M -12.81M -12.53M -559M